Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Stenosis | 23 | 2024 | 878 | 6.050 |
Why?
|
Endovascular Procedures | 30 | 2024 | 2165 | 4.250 |
Why?
|
Endarterectomy, Carotid | 12 | 2024 | 564 | 3.400 |
Why?
|
Stents | 26 | 2024 | 3314 | 2.140 |
Why?
|
Carotid Artery Diseases | 7 | 2023 | 883 | 1.750 |
Why?
|
Stroke | 22 | 2023 | 9962 | 1.700 |
Why?
|
Blood Vessel Prosthesis Implantation | 12 | 2024 | 1446 | 1.560 |
Why?
|
Peripheral Arterial Disease | 6 | 2024 | 1306 | 1.490 |
Why?
|
Vascular Surgical Procedures | 9 | 2023 | 1475 | 1.470 |
Why?
|
Protamines | 3 | 2021 | 112 | 1.420 |
Why?
|
Lower Extremity | 4 | 2024 | 1194 | 1.320 |
Why?
|
Femoral Artery | 8 | 2023 | 835 | 1.230 |
Why?
|
Embolism | 2 | 2023 | 408 | 1.210 |
Why?
|
Thromboembolism | 3 | 2022 | 1017 | 1.010 |
Why?
|
Aortic Aneurysm, Abdominal | 11 | 2023 | 1223 | 0.960 |
Why?
|
Catheterization, Peripheral | 4 | 2020 | 345 | 0.900 |
Why?
|
Heparin Antagonists | 2 | 2020 | 34 | 0.890 |
Why?
|
Gelatin | 1 | 2024 | 221 | 0.800 |
Why?
|
Ischemia | 3 | 2020 | 1893 | 0.760 |
Why?
|
Arginine | 1 | 2024 | 934 | 0.720 |
Why?
|
Vascular System Injuries | 1 | 2024 | 247 | 0.700 |
Why?
|
Aorta, Abdominal | 2 | 2019 | 625 | 0.670 |
Why?
|
Balloon Occlusion | 1 | 2020 | 127 | 0.660 |
Why?
|
Groin | 1 | 2019 | 107 | 0.630 |
Why?
|
Treatment Outcome | 41 | 2024 | 65017 | 0.610 |
Why?
|
RNA, Small Interfering | 2 | 2024 | 3442 | 0.610 |
Why?
|
Risk Assessment | 23 | 2023 | 24123 | 0.580 |
Why?
|
Intermittent Claudication | 2 | 2023 | 306 | 0.570 |
Why?
|
Risk Factors | 38 | 2024 | 74359 | 0.560 |
Why?
|
Heparin | 1 | 2024 | 1652 | 0.560 |
Why?
|
Patient Discharge | 3 | 2023 | 3476 | 0.540 |
Why?
|
Transfection | 1 | 2024 | 5781 | 0.540 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 422 | 0.530 |
Why?
|
Postoperative Complications | 14 | 2024 | 15697 | 0.520 |
Why?
|
Carotid Arteries | 5 | 2023 | 951 | 0.520 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 656 | 0.520 |
Why?
|
Angiography | 1 | 2020 | 1605 | 0.490 |
Why?
|
Angioplasty | 2 | 2019 | 361 | 0.490 |
Why?
|
Retrospective Studies | 39 | 2024 | 80372 | 0.470 |
Why?
|
Aortic Rupture | 3 | 2023 | 317 | 0.460 |
Why?
|
Propensity Score | 3 | 2020 | 1928 | 0.460 |
Why?
|
Myocardial Infarction | 5 | 2023 | 11891 | 0.450 |
Why?
|
Arteries | 3 | 2023 | 1126 | 0.430 |
Why?
|
Time Factors | 25 | 2024 | 40165 | 0.430 |
Why?
|
Aortic Diseases | 1 | 2019 | 736 | 0.420 |
Why?
|
Blood Vessel Prosthesis | 7 | 2024 | 956 | 0.420 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1097 | 0.410 |
Why?
|
Renal Artery Obstruction | 1 | 2013 | 224 | 0.400 |
Why?
|
Registries | 9 | 2020 | 8469 | 0.370 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1502 | 0.360 |
Why?
|
Hospital Mortality | 9 | 2021 | 5425 | 0.360 |
Why?
|
Aged, 80 and over | 23 | 2024 | 58995 | 0.330 |
Why?
|
Aged | 36 | 2024 | 169152 | 0.300 |
Why?
|
Limb Salvage | 2 | 2020 | 465 | 0.270 |
Why?
|
Eligibility Determination | 2 | 2021 | 421 | 0.270 |
Why?
|
United States | 17 | 2024 | 72461 | 0.250 |
Why?
|
Humans | 55 | 2024 | 760621 | 0.240 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2024 | 78 | 0.240 |
Why?
|
Cell-Penetrating Peptides | 1 | 2024 | 49 | 0.230 |
Why?
|
Pipecolic Acids | 1 | 2024 | 78 | 0.230 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5889 | 0.230 |
Why?
|
beta 2-Microglobulin | 1 | 2024 | 328 | 0.220 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2020 | 698 | 0.220 |
Why?
|
Hirudins | 1 | 2024 | 194 | 0.220 |
Why?
|
Thrombospondins | 1 | 2024 | 193 | 0.220 |
Why?
|
Male | 38 | 2024 | 359744 | 0.210 |
Why?
|
Ribs | 1 | 2024 | 252 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.210 |
Why?
|
Diffusion of Innovation | 2 | 2024 | 730 | 0.200 |
Why?
|
Length of Stay | 4 | 2020 | 6479 | 0.200 |
Why?
|
Female | 36 | 2024 | 391270 | 0.190 |
Why?
|
Carotid Artery, Internal | 1 | 2024 | 438 | 0.190 |
Why?
|
Antithrombins | 1 | 2024 | 313 | 0.190 |
Why?
|
Databases, Factual | 8 | 2021 | 8035 | 0.190 |
Why?
|
Punctures | 2 | 2020 | 370 | 0.190 |
Why?
|
Vascular Patency | 1 | 2024 | 901 | 0.190 |
Why?
|
Prosthesis Design | 4 | 2020 | 2135 | 0.180 |
Why?
|
Hyperplasia | 1 | 2024 | 1155 | 0.180 |
Why?
|
Middle Aged | 22 | 2024 | 220352 | 0.170 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2024 | 686 | 0.170 |
Why?
|
Chronic Disease | 3 | 2020 | 9287 | 0.170 |
Why?
|
Gene Knockdown Techniques | 1 | 2024 | 1617 | 0.170 |
Why?
|
Subclavian Artery | 1 | 2020 | 134 | 0.170 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 3465 | 0.170 |
Why?
|
Decompression, Surgical | 1 | 2024 | 604 | 0.160 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15289 | 0.160 |
Why?
|
Endoleak | 1 | 2018 | 110 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.150 |
Why?
|
Learning Curve | 1 | 2019 | 231 | 0.150 |
Why?
|
Aortography | 1 | 2018 | 420 | 0.140 |
Why?
|
Ischemic Attack, Transient | 2 | 2020 | 901 | 0.140 |
Why?
|
Prosthesis-Related Infections | 1 | 2022 | 487 | 0.140 |
Why?
|
History, 20th Century | 1 | 2024 | 2773 | 0.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 694 | 0.130 |
Why?
|
Patient Selection | 4 | 2019 | 4283 | 0.120 |
Why?
|
Recombinant Proteins | 1 | 2024 | 6538 | 0.120 |
Why?
|
Sulfonamides | 1 | 2024 | 1977 | 0.120 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2380 | 0.110 |
Why?
|
Treatment Failure | 1 | 2019 | 2648 | 0.100 |
Why?
|
Endarterectomy | 1 | 2013 | 195 | 0.100 |
Why?
|
Peptide Fragments | 1 | 2024 | 5125 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3539 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1114 | 0.090 |
Why?
|
Hemorrhage | 2 | 2022 | 3600 | 0.090 |
Why?
|
Reminder Systems | 1 | 2014 | 387 | 0.090 |
Why?
|
Odds Ratio | 2 | 2020 | 9716 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2024 | 3201 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12808 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1824 | 0.080 |
Why?
|
Anticoagulants | 1 | 2024 | 4897 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1830 | 0.080 |
Why?
|
Quality Improvement | 1 | 2023 | 3836 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2024 | 10446 | 0.070 |
Why?
|
Heart Arrest | 1 | 2018 | 1506 | 0.070 |
Why?
|
Rats | 1 | 2024 | 23711 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10551 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13314 | 0.070 |
Why?
|
Health Services Research | 1 | 2014 | 1810 | 0.070 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 587 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3150 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4048 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6786 | 0.060 |
Why?
|
Subclavian Vein | 1 | 2024 | 58 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 3052 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12159 | 0.060 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1779 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3388 | 0.060 |
Why?
|
Insulin | 1 | 2018 | 6597 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3455 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3323 | 0.060 |
Why?
|
Canada | 2 | 2019 | 2128 | 0.050 |
Why?
|
Cohort Studies | 2 | 2023 | 41335 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2023 | 177 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15840 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20080 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2013 | 2781 | 0.050 |
Why?
|
Medication Adherence | 1 | 2014 | 2165 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8552 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 224 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2024 | 377 | 0.050 |
Why?
|
Reoperation | 2 | 2022 | 4291 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2024 | 560 | 0.040 |
Why?
|
Constriction | 1 | 2019 | 172 | 0.040 |
Why?
|
Aspirin | 2 | 2022 | 3364 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10790 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3841 | 0.040 |
Why?
|
Osteotomy | 1 | 2024 | 836 | 0.040 |
Why?
|
Gene Transfer Techniques | 1 | 2024 | 1204 | 0.040 |
Why?
|
Embolic Protection Devices | 1 | 2019 | 44 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 147 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2018 | 384 | 0.040 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.040 |
Why?
|
Animals | 3 | 2024 | 167963 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10344 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10547 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2024 | 2108 | 0.030 |
Why?
|
Forecasting | 1 | 2024 | 2932 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2023 | 1669 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12293 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2018 | 948 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2295 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1386 | 0.030 |
Why?
|
Age Factors | 2 | 2019 | 18416 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2014 | 742 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1958 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25942 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9411 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5794 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5066 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17165 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4081 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3334 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6381 | 0.010 |
Why?
|
Clinical Competence | 1 | 2019 | 4783 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5423 | 0.010 |
Why?
|
Adult | 3 | 2024 | 219994 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21392 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23376 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 58741 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 87810 | 0.010 |
Why?
|
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_